US Bancorp
SLDB icon

US Bancorp’s Solid Biosciences SLDB Stock Holding History

US Bancorp’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Sell
12,276
-942
-7% -$7.14K ﹤0.01% 2344
2026
Q1 		$95.2K Buy
13,218
+12,918
+4,306% +$83K ﹤0.01% 2412
2025
Q4 		$1.69K Hold
300
– – ﹤0.01% 3786
2025
Q3 		$1.85K Hold
300
– – ﹤0.01% 3767
2025
Q2 		$1.46K Sell
300
-36
-11% -$127 ﹤0.01% 3912
2025
Q1 		$1.24K Buy
+336
New +$1.44K ﹤0.01% 3957
2024
Q4 		– Sell
-27
Closed -$188 – 4253
2024
Q3 		$188 Buy
+27
New +$219 ﹤0.01% 4017

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

US Bancorp's SLDB Position: Q2 2026 in Review

US Bancorp reduced its Solid Biosciences (SLDB) stake by 7.1% in Q2 2026, selling an estimated $7.14K and leaving 12,276 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

US Bancorp first reported a position in SLDB in Q3 2024 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • US Bancorp held 12,276 shares of Solid Biosciences worth $123K as of Q2 2026.
  • US Bancorp sold 942 Solid Biosciences shares in Q2 2026, an estimated $7.14K.
  • Solid Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2344 holding.
  • US Bancorp first reported a position in Solid Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.